A case report of successful elimination of recurrent ventricular tachycardia by repeated stereotactic radiotherapy: the importance of accurate target volume delineation.

Case report Catheter ablation Stereotactic radiotherapy Ventricular tachycardia

Journal

European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 29 06 2020
revised: 10 08 2020
accepted: 15 11 2020
entrez: 18 2 2021
pubmed: 19 2 2021
medline: 19 2 2021
Statut: epublish

Résumé

Stereotactic body radiotherapy (SBRT) has emerged recently as a novel therapeutic alternative for patients with ventricular tachycardias (VTs) resistant to convetional treatment. Nevertheless, many aspects related to SBRT are currently unknown. A 66-year-old man with ischaemic heart disease, a history of coronary artery bypass graft surgery and left ventricular dysfunction was referred for recurrent symptomatic episodes of slow VT (108 b.p.m.). The arrhythmia was resistant to antiarrhythmic drug therapy with amiodarone and repeated catheter ablation. The patient was scheduled to SBRT, however, the first session failed to suppress VT recurrences. After 20 months, the patient underwent re-do ablation procedure that revealed a newly developed scar with its core adjacent to the presumed critical part of the VT substrate. Catheter ablation again failed to eliminate VT and the second session of SBRT was scheduled. To improve targeting of the VT substrate for SBRT, we applied our recently developed original method for integration of data from the electroanatomical mapping system with computer tomography images. The second session of SBRT with precise targeting using the novel strategy led within 3 months to the successful elimination of VT. This case report describes a patient in whom the recurrent VT was abolished only by properly targeted SBRT. Above all, the case highlights the importance of precise identification and targeting for SBRT. Our case also documents

Sections du résumé

BACKGROUND BACKGROUND
Stereotactic body radiotherapy (SBRT) has emerged recently as a novel therapeutic alternative for patients with ventricular tachycardias (VTs) resistant to convetional treatment. Nevertheless, many aspects related to SBRT are currently unknown.
CASE SUMMARY METHODS
A 66-year-old man with ischaemic heart disease, a history of coronary artery bypass graft surgery and left ventricular dysfunction was referred for recurrent symptomatic episodes of slow VT (108 b.p.m.). The arrhythmia was resistant to antiarrhythmic drug therapy with amiodarone and repeated catheter ablation. The patient was scheduled to SBRT, however, the first session failed to suppress VT recurrences. After 20 months, the patient underwent re-do ablation procedure that revealed a newly developed scar with its core adjacent to the presumed critical part of the VT substrate. Catheter ablation again failed to eliminate VT and the second session of SBRT was scheduled. To improve targeting of the VT substrate for SBRT, we applied our recently developed original method for integration of data from the electroanatomical mapping system with computer tomography images. The second session of SBRT with precise targeting using the novel strategy led within 3 months to the successful elimination of VT.
DISCUSSION CONCLUSIONS
This case report describes a patient in whom the recurrent VT was abolished only by properly targeted SBRT. Above all, the case highlights the importance of precise identification and targeting for SBRT. Our case also documents

Identifiants

pubmed: 33598611
doi: 10.1093/ehjcr/ytaa516
pii: ytaa516
pmc: PMC7873794
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ytaa516

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

HeartRhythm Case Rep. 2018 Oct 24;5(1):44-47
pubmed: 30693205
Circ Arrhythm Electrophysiol. 2018 May;11(5):e006108
pubmed: 29700057
Circ Arrhythm Electrophysiol. 2011 Feb;4(1):49-55
pubmed: 21131557
Heart Rhythm. 2010 Jun;7(6):802-10
pubmed: 20156591
Radiother Oncol. 2018 Aug;128(2):189-191
pubmed: 29753550
N Engl J Med. 2017 Dec 14;377(24):2325-2336
pubmed: 29236642
J Am Coll Cardiol. 2019 Aug 20;74(7):905-927
pubmed: 31416535
J Clin Oncol. 2017 May 1;35(13):1387-1394
pubmed: 28113017
Europace. 2019 Aug 1;21(8):1143-1144
pubmed: 31075787
Int J Radiat Oncol Biol Phys. 2019 Mar 2;:
pubmed: 30836165
Heart Lung Circ. 2019 Jan;28(1):84-101
pubmed: 30385114
Europace. 2019 Jul 1;21(7):1088-1095
pubmed: 31121018
HeartRhythm Case Rep. 2019 Mar 21;5(6):329-332
pubmed: 31285992
Circulation. 2019 Jan 15;139(3):313-321
pubmed: 30586734

Auteurs

Petr Peichl (P)

Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Vídeňská 1958/9, Prague 140 21, Czech Republic.

Marek Sramko (M)

Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Vídeňská 1958/9, Prague 140 21, Czech Republic.

Jakub Cvek (J)

Department of Oncology, University Hospital Ostrava, 17. listopadu 1790/5, Ostrava, 708 00, Czech Republic.

Josef Kautzner (J)

Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Vídeňská 1958/9, Prague 140 21, Czech Republic.

Classifications MeSH